AI TrackerFrontier desk · AEST
Back to news
highaitech

OpenAI acquires Orchestra Bio

OpenAI · 21 Oct 2026, 06:35 AEST

OpenAI has acquired the biotech startup Orchestra Bio to enhance its life sciences research capabilities. The acquisition will integrate Orchestra's technology into OpenAI's Rosalind model and related tools for researchers.

Key facts

Read aloud

Open A I has acquired the biotech startup Orchestra Bio to enhance its life sciences research capabilities. The acquisition will integrate Orchestra's technology into Open A I's Rosalind model and related tools for researchers. Open A I says it's adding Orchestra's team and technology to work on Rosalind, its A I model for life sciences research, and to its related Rosalind Workbench tool, a harness that aims to help researchers plan experiments and analyze results. Open A I on Tuesday acquired a four-year-old A I biotech software startup called Orchestra Bio, the company announced via its website. Terms of the deal were not disclosed, but the startup had reportedly raised around twenty dollars million as of twenty twenty five from backers like Andreessen Horowitz, Atria, and 8VC. Orchestra creates A I agents that help biotech companies manage the minutiae of drug discovery operations, from tracking finances to resolving scheduling issues with clinical trials.

Sources in this cluster